2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
7
Lymphoma, Non-Hodgkin
5
Neoplasms
4
Lymphoma
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Myelodysplastic Syndromes
3
Lung Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Heart Failure
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Dyslipidemias
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Interventions
Nebivolol
1
Methods
1
Exercise Therapy
1
Exercise
1
Electrocardiography
1
Echocardiography
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ventricular Dysfunction, Left
×
Electrocardiography
×
Clear all
NCT05939089
2023-07-11
CASPER
Istanbul University
Completed
54 enrolled